to promote these responses (fig. S6C). Thus, the
poised type 2 immune potential of commensal-
specific TC17 cells allows for local adaptation to
injury, thereby promoting tissue repair.
Conclusion
Barrier tissues are constitutively exposed to en-
vironmental stressors and are primary targets of
chronic inflammatory disorders. The mainte-
nance of tissue integrity and function represent
a complex challenge that requires both resilience
and adaptation. Under steady-state conditions,
tissue resilience is, in part, mediated by innate
and adaptive immunity to the microbiota, which
reinforces barrier function and immunity ( 5 ).
Our results show that adaptation of tissue to
injuries can also be mediated by immunity to
the microbiota, a fundamental but poorly under-
stood class of immunity. Notably, we found that
homeostatic immunity to bacteria or fungal com-
mensals is characterized by the coexpression of
paradoxical programs, allowing commensal-
specific T cells, when entering and persisting
within tissues, to adopt a type 17 program com-
patiblewithtissuehomeostasisandimmunity
while maintaining a type 2–poised state. As such,
in the context of injury and consequent exposure
to inflammatory mediators and cognate antigens,
commensal-specific T cells rapidly release type 2
cytokines, allowing these cells to exert pleiotropicand contextual functionsincluding tissue repair.
Thus,wedescribeatissuecheckpointthatrelies
ontheremarkableplasticityandadaptabilityof
tissue-resident commensal-specific T cells. We pro-
pose that this feature may also have important
implications in the etiology of tissue-specific
inflammatory disorders. Given the extraordinary
number of both commensal-derived antigens and
T cells at barrier sites, such a feature may represent
a fundamental component of host immunity.Materials and methods
Mice
Wild-type (WT) C57BL/6 Specific Pathogen
Free(SPF)micewerepurchasedfromTaconicHarrisonet al.,Science 363 , eaat6280 (2019) 4 January 2019 7of11
ABMediaIL-1α
IL-1β
IL-18IL-25IL-33TSLP00.51.01.52.0IL-17A (ng/ml)**Tc17C D050100150IFN-γ (ng/ml)MediaIL-1α
IL-1β
IL-18IL-25IL-33TSLP
Tc1**
**MediaIL-1α
IL-1β
IL-18IL-25IL-33TSLP050100150200IL-5 (pg/ml)Tc17**
**
**MediaIL-1α
IL-1β
IL-18IL-25IL-33TSLP0100200300400500IL-13 (pg/ml)Tc17**
***EF
i.d. PBS i.d. IL-18IL-17AIL-525±4 0.2±0.10.6±0.316±5 4±215±3Tc17G22±4 1±0.32±13±1 03±110±3 3±217±52±1 0.3±0.118±4IL-17ACD4+ CCR6+
i.d. PBSIL-5CD4+ CCR6+
i.d. IL-18CD4+ CCR6-
i.d. PBSCD4+ CCR6-
i.d. IL-18i.d. PBS
i.d. IL-18
**05101520IL-5+ (%)Tc1 Tc170510IL-13+ (%)**Tc1 Tc170510152025IFN-+γ
(%)Tc1 Tc17IL-17A+ (%)0
Tc1 Tc17102030 *HIChitin*05101520PBS IL-18*IL-5+ Th17 (%)Chitin*02468IL-13+ Th17 (%)PBS IL-18*05101520PBSIL-18*Chitin*IL-5+ Tc17 (%)02468IL-13+ Tc17 (%)PBS Chitin*IL-18*Il18r1fl/fl Cd4CreIl18r1fl/flIl18r1fl/fl Cd4CreIl18r1fl/flFig. 5. Tissue alarmins license type 2 cytokine production from commensal-specific
T cells.(AtoD)TC17 (CD8+CCR6+) and TC1 (CD8+CCR6−) cells were isolated from
the skin ofS. epidermidis–colonized wild-type mice and cultured in vitro with agonistic
anti-CD3emAb and the indicated cytokines. Cell culture supernatants were assayed
for cytokine production after 24 hours of culture. (E) Representative contour plots
of IL-5 and IL-17A production potential byS. epidermidis–induced TC17 cells after i.d.
injection with PBS or IL-18. (F) Representative contour plots of IL-5 and IL-17A production
potential by skin CD4+Foxp3−T cells fromS. epidermidis–colonized wild-type mice after
i.d. injection with PBS or IL-18. (G) Frequencies of TC17 and TC1 cells with indicated
cytokine production potential from the skin ofS. epidermidis–colonized wild-type mice
after i.d. injection of PBS or IL-18. (HandI) Frequencies of TC17 (H) and TH17 (I) cells with
indicated cytokine production potential from the skin ofS. epidermidis–colonized
Cd4CreIl18r1fl/fland control mice after i.d. injection with PBS, IL-18, or chitin. Numbers in
representative plots indicate means ± SD. Bar graphs show means ± SD. Data represent at least two experiments with three to six mice per group.
*P< 0.05, **P< 0.01 as calculated using one-way [(A) to (D), (G)] or two-way [(H), (I)] ANOVA with Holm-Šidák multiple-comparison test.
RESEARCH | RESEARCH ARTICLE
on January 7, 2019^http://science.sciencemag.org/Downloaded from